Søgning på udtrykket 'covid' giver 85 resultater


Dokumenter [12] Sider [3] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [12]

Ændringer siden version 28: Moderat risikogruppe udgår. Gravide udgår som risikogruppe. Skærpelse af kriterier for opstart af Paxlovid (nu kun højrisiko patient med indikation).

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Invitation til møde den 20. maj 2022

Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19

Sider [3]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…

…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Infectious Diseases
21.07.2024
Abstract . Background . To address the need for novel COVID-19 therapies, we evaluated the fully-human polyclonal antibody product SAB-185 in a phase 3 clinical trial.Methods . Non-hospitalized high-risk adults within 7 days of COVID-19 symptom onset were randomized 1:1 to open-label SAB-185 3,840 units/kg or casirivimab/imdevimab 1200 mg. Non-inferiority comparison was undertaken for the pre-Omicron population (casirivimab/imdevimab expected to be fully active) and superiority comparison for the Omicron po…
BMC Infectious Diseases
20.07.2024
… Abstract. . Background. Camostat mesylate, an oral serine protease inhibitor, is a powerful TMPRSS2 inhibitor and has been reported as a possible antiviral treatment against COVID-19. Therefore, we aim to assess the safety and efficacy of camostat mesylate for COVID-19 treatment. . . . Methods. A systematic review and meta-analysis synthesizin…
Science Advances
20.07.2024
Science Advances, Volume 10, Issue 29, July 2024.
PLoS One Infectious Diseases
20.07.2024
by Astrid Loiseau, Tiphaine Davit-Béal, Damien Brézulier . Purpose The Covid-19 epidemic has imposed profound changes on the practice of orthodontics. It was in this anxiety-inducing context that drastic measures were imposed on orthodontists. The main aim of this online survey is to highlight the measures that are still in place in French orthodontic practices three years after the emergence of the pandemic. Methods A cross-sectional online survey was distributed to French orthodontists from march to J…
PLoS One Infectious Diseases
20.07.2024
by Mahsa Karimi, Mohammad Reza Khami, Shabnam Varmazyari, Ahmad Reza Shamshiri, Mahmoud Hormozi, Nourhan M. Aly, Morẹ́nikẹ́ Oluwátóyìn Foláyan . Background The Coronavirus disease 2019 pandemic increased global psychological distress, emotional distress, and sleep disturbances, all known risk factors for compromised oral health. Despite this, there is limited understanding of the impacts of these psychological factors on oral health in certain populations, including Iranians. Thus, the present st…
PLoS One Infectious Diseases
20.07.2024
by Kasim Abdulai, Abdul Rauf Alhassan, Safianu Osman Aleboko, Mohammed Doobia Ahmed, Awal Seidu Mohammed, Odei-Asare Fremah Adom, Rhoda Kumah . Background The coronavirus Disease 2019 (COVID-19) pandemic has brought about unique challenges in healthcare and nutrition, particularly for people living with HIV (PLHIV). Understanding their dietary patterns and nutritional status is crucial for developing targeted interventions and improving health outcomes. Therefore, this study assessed the dietary diversity …
Antimicrobial Agents And Chemotherapy
19.07.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
BMJ Open
19.07.2024
. Objectives. Parents’ decisions to vaccinate their children against COVID-19 are complex and often informed by discussions with primary care physicians. However, little is known about physicians’ perspectives on COVID-19 vaccinations for children or their experiences counselling parents in their decision-making. We explored physicians’ experiences providing COVID-19 vaccination recommendations to parents and their reflections on the contextual factors that shaped these experiences. . Design. We cond…
BMC Infectious Diseases
19.07.2024
. Abstract. . Objective. To assess the evolution of the COVID-19 pandemic in Brazil and its macro-regions, considering disease incidence and mortality rates, as well as identifying territories with still rising disease indices and evaluating vaccine coverage and population adherence to COVID-19 immunization. . . . Methods. An ecological stud…
BMC Infectious Diseases
19.07.2024
. Abstract. . Background. To explore the impact of diabetes on the clinical features and prognosis of COVID-19 and assess the influence of glucocorticoid use on the prognosis of patients with COVID-19 and diabetes. . . . Methods. This retrospective multicenter cohort study included patients admitted between December 2022 and January 2023. Th…
PLoS One Infectious Diseases
19.07.2024
by Faisal Salman Alshaikh, Brian Godman, Oula Nawaf Sindi, R. Andrew Seaton, Amanj Kurdi .
New England Journal of Medicine
19.07.2024
New England Journal of Medicine, Volume 391, Issue 3, Page 224-234, July 18, 2024.
New England Journal of Medicine
19.07.2024
New England Journal of Medicine, Ahead of Print.
Antimicrobial Agents And Chemotherapy
18.07.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Journal of Acquired Immune Deficiency Syndromes
18.07.2024
Background: . The WHO is committed to strengthening access to pre-exposure prophylaxis (PrEP) for HIV prevention and its integration into primary care services. Unfortunately, the COVID-19 pandemic has disrupted the delivery of primary care, including HIV-related services. To determine the extent of this disruption, we conducted a systematic review and meta-analysis of the changes in access to PrEP services during the pandemic and the reasons for these changes. Methods: . A search was conducted using Pubm…
Journal of Infectious Diseases
18.07.2024
Abstract . Host metabolic dysregulation, especially in tryptophan metabolism, is intricately linked to COVID-19 severity and its post-acute sequelae (Long COVID). People living with HIV (PLWH) experience similar metabolic dysregulation and face an increased risk of developing Long COVID. However, whether pre-existing HIV-associated metabolic dysregulations contribute in predisposing PLWH to severe COVID-19 outcomes remains underexplored. Analyzing pre-pandemic samples from PLWH with documented post-infectio…
BMJ Open
18.07.2024
. Objectives. To investigate the association between exposure to potentially inappropriate medication (PIM) and poor prognosis of COVID-19 in older adults, controlling for comorbidity and sociodemographic factors. . Design and setting. Nationwide retrospective cohort study based on the national registry of COVID-19 patients, established through the linkage of South Korea’s national insurance claims database with the Korea Disease Control and Prevention Agency registry of patients with COVID-19, up to 31 …
BMJ Open
18.07.2024
. Objectives. The study explored the perceived impacts of COVID-19 and its associated policies and social restrictions on health, self-management and access to healthcare. . Design. Cross-sectional observational (online survey) and qualitative study (semi-structured interviews and thematic analysis). . Setting. Australia. . Participants. People with self-reported cardiovascular disease (CVD) and/or risk factors. . Results. Survey responses were collected from 690 participants (43.8% women, 40.1% over 65…
BMJ Open
18.07.2024
. Background. The novel COVID-19 was rapidly spreading and was highly contagious. COVID-19 caused over 6 million deaths worldwide, with high mortality rates, particularly in severe cases. . Objective. This study aimed to investigate whether serum albumin-neutrophil count to lymphocyte count ratio (NLR) score (ANS) could be used as a prognostic indicator of COVID-19 severity. . Design. A retrospective study. . Participants. Based on the WHO diagnostic criteria, patients were classified as either non-sever…
Journal of Medical Virology
17.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
20.07.2024
Your chances of developing long COVID have significantly decreased since the pandemic began, according to a new study published in the New England Journal of Medicine. . WebMD Health News
Eurosurveillance latest updates
20.07.2024
. Background. The COVID-19 pandemic and the emergence of Candida auris have changed the epidemiological landscape of candidaemia worldwide. . . Aim. We compared the epidemiological trends of candidaemia in a Greek tertiary academic hospital before (2009–2018) and during the early COVID-19 (2020–2021) and late COVID-19/early post-pandemic (2022–2023) era. . . Methods. Incidence rates, species distribution, antifungal susceptibility profile and antifungal consumption were recorded, and one-way ANO…
Medscape Infectious Diseases
18.07.2024
Recent evidence suggests long COVID is primarily an autonomic nervous system disorder. But the devil is in the details. . Medscape Medical News
Medscape Infectious Diseases
16.07.2024
Remote clinical trials may be the key to recruiting more long COVID sufferers — and expediting new inroads to treatment. . Medscape Medical News
Medscape Infectious Diseases
13.07.2024
Some dairy farmers are resisting Michigan's nation-leading efforts to stop the spread of bird flu for fear their incomes will suffer from added costs and hurt rural. . Reuters Health Information
Eurosurveillance latest updates
12.07.2024
. Background. As Ireland prepared for an autumn 2023 COVID-19 vaccination booster campaign, there was concern that vaccine fatigue would affect uptake, which has been abating. . . Aim. This study aimed to quantify the direct impact of the COVID-19 vaccination programme in Ireland on averted COVID-19-related outcomes including symptomatic presentations to primary care/community testing centres, emergency department (ED) presentations, hospitalisations, intensive care unit (ICU) admissions and deaths, in i…
Medscape Infectious Diseases
3.07.2024
Those who treat and research long COVID warn that viral persistence and reactivation are real risks for some patients. . Medscape Medical News
Medscape Infectious Diseases
1.07.2024
AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug,. . Reuters Health Information
Medscape Infectious Diseases
28.06.2024
The U.S. Centers for Disease Control and Prevention has recommended that individuals aged six months and older should be given an updated COVID-19 vaccine for the 2024-25. . Reuters Health Information
Medscape Infectious Diseases
26.06.2024
Critics contend the NIH's RECOVER program needs to expand its focus and pivot in new research directions. RECOVER researchers cite gains and stress patience. . Medscape Medical News
Medscape Infectious Diseases
25.06.2024
The COVID-19 pandemic has been associated with reported declines in cancer screenings. Now a new study suggested these decreases extended through 2022 for cervical cancer screening in particular. . Medscape Medical News
Eurosurveillance latest updates
22.06.2024
. Background. Non-severe adverse events (AE) including pain at injection site or fever are common after COVID-19 vaccination. . . Aim. To describe determinants of AE after COVID-19 vaccination and investigate the association between AE and pre- and post-vaccination antibody concentrations. . . Methods. Participants of an ongoing prospective cohort study (VASCO) completed a questionnaire on AE within 2 months after vaccination and provided 6 monthly serum samples during May 2021–November 2022. Logist…
Medscape Infectious Diseases
19.06.2024
Is a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome? . Medscape
Medscape Infectious Diseases
13.06.2024
Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared. . Reuters Health Information
Medscape Infectious Diseases
12.06.2024
A new report defines the infection-associated chronic condition as lasting at least 3 months, with single or multiple symptoms and without need for confirmatory tests. . Medscape Medical News
Medscape Infectious Diseases
11.06.2024
Four years in, while some progress has been made, lack of research, funding, and clinics keeps many physicians playing diagnostic and treatment whack-a-mole. . Medscape Medical News
Medscape Infectious Diseases
6.06.2024
Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor of recommending that COVID-19 vaccines for 2024-25 should target a strain within. . Reuters Health Information
Medscape Infectious Diseases
6.06.2024
Former top U.S. infectious disease expert Dr. Anthony Fauci strongly denied suppressing the theory that COVID-19 originated from a lab leak in China, telling lawmakers he. . Reuters Health Information
Medscape Infectious Diseases
4.06.2024
Without more robust research, long COVID progress will continue to be slow going. A tech entrepreneur (and long COVID sufferer) is working to change that. . Medscape Medical News
Medscape Infectious Diseases
4.06.2024
A pioneer in dysautonomia shares pearls on approaching patients with long COVID and postural orthostatic tachycardia syndrome. . Medscape

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.14.5
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.787 s

Cookies og privatliv